The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial

N.D. Prins, W.A. van der Flier, D.L. Knol, N.C. Fox, H.R. Brashear, J.S. Nye, F. Barkhof, P. Scheltens

    Research output: Contribution to JournalArticleAcademicpeer-review

    Fingerprint

    Dive into the research topics of 'The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial'. Together they form a unique fingerprint.

    Neuroscience

    Pharmacology, Toxicology and Pharmaceutical Science